Nika C Gloyeske1, David J Dabbs, Rohit Bhargava. 1. Magee-Womens Hospital of University of Pittsburgh Medical Center, 300 Halket St, Pittsburgh, PA 15213; rbhargava@mail.magee.edu.
Abstract
OBJECTIVES: Estrogen receptor (ER) level can be semiquantified by immunohistochemistry (IHC) using the H-score. The score, given as the sum of the percent staining multiplied by the intensity level, ranges from 0 to 300. METHODS: Forty-nine ER+/HER2- invasive tumors with low ER expression (H-scores of 1-100, representing approximately 5% of all tumors) were studied for various morphologic parameters, progesterone receptor (PR), and Ki-67 IHC. RESULTS: Eighteen of 49 patients received neoadjuvant chemotherapy. The morphologic analysis showed that these tumors are often grade 3 and frequently demonstrate a sheet-like growth pattern, an intratumoral lymphocytic inflammatory infiltrate, and necrosis. Eighty percent of tumors showed a Ki-67 proliferation index of more than 50%, and 94% were PR-. Of the 18 patients who received neoadjuvant chemotherapy, six (33%) achieved pathologic complete response. CONCLUSIONS: The low ER+/HER2- cases have morphologic features and a response to the chemotherapy rate that are more similar to triple-negative tumors than the usual type of ER+ tumors.
OBJECTIVES:Estrogen receptor (ER) level can be semiquantified by immunohistochemistry (IHC) using the H-score. The score, given as the sum of the percent staining multiplied by the intensity level, ranges from 0 to 300. METHODS: Forty-nine ER+/HER2- invasive tumors with low ER expression (H-scores of 1-100, representing approximately 5% of all tumors) were studied for various morphologic parameters, progesterone receptor (PR), and Ki-67 IHC. RESULTS: Eighteen of 49 patients received neoadjuvant chemotherapy. The morphologic analysis showed that these tumors are often grade 3 and frequently demonstrate a sheet-like growth pattern, an intratumoral lymphocytic inflammatory infiltrate, and necrosis. Eighty percent of tumors showed a Ki-67 proliferation index of more than 50%, and 94% were PR-. Of the 18 patients who received neoadjuvant chemotherapy, six (33%) achieved pathologic complete response. CONCLUSIONS: The low ER+/HER2- cases have morphologic features and a response to the chemotherapy rate that are more similar to triple-negative tumors than the usual type of ER+ tumors.
Entities:
Keywords:
Low ER+/HER2-; Morphology; Response to neoadjuvant chemotherapy
Authors: Stefan Stefanovic; Ralph Wirtz; Thomas M Deutsch; Andreas Hartkopf; Peter Sinn; Zsuzsanna Varga; Bettina Sobottka; Lakis Sotiris; Florin-Andrei Taran; Christoph Domschke; Andre Hennigs; Sara Y Brucker; Christof Sohn; Florian Schuetz; Andreas Schneeweiss; Markus Wallwiener Journal: Oncotarget Date: 2017-05-19
Authors: Richard Sleightholm; Beth K Neilsen; Safwan Elkhatib; Laura Flores; Saihari Dukkipati; Runze Zhao; Songita Choudhury; Bret Gardner; Joey Carmichael; Lynette Smith; Nathan Bennion; Andrew Wahl; Michael Baine Journal: J Clin Med Res Date: 2021-01-12